Skip to content
Seqlense EUR-Lex

Commission Implementing Regulation (EU) 2022/489 of 25 March 2022 amending Implementing Regulation (EU) No 540/2011 as regards the approval periods of the active substances flubendiamide, L-ascorbic acid, spinetoram and spirotetramat (Text with EEA relevance)

CELEX
32022R0489
Document type
REG_IMPL
Sector
Legislation
Date of document
2022-03-25
In force since
2022-04-17
Status
In force

Text

Article-level text, parsed from the formex manifestation.

Article 1

The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

Relations

What this act cites, and what cites it.

Show relations

Versions

Point-in-time consolidated versions of this act.

Show versions